Welcome on Board ,,, Best of Luck with your Investments,,,...

Welcome on Board ,,, Best of Luck with your Investments,,, December the 10th is the Interim Phase II Data Presentation in the USA ..
SNT are presenting , this is not just another Poster Presentation ,, SNT are a Mainstage Player...you don't book yourself on the Mainstage in front of 30,000 global attendees to promote failure..... There was a solid efficacy indication from the Phase I Trial,,, now looks to be replicated with deeper data from the Phase II...

My primary interest is in SNT 6302 as I believe that will be a First In Class Medicine that will become Standard of Care for any and all surgical scarring prevention and secondary for the reduction in established scars and burns...$$$$$ easily understood , simple regulatory process for approval as its a dermal application of a topical cream,,, plus on that front we have a globally prominent world renowned product Champion , Fiona Woods, Australian of the Year and Director of the Burns Unit at the Royal Perth Hospital ,,, when Fiona picks up the phone ,, people listen , her ability to provide mainstream media exposure to this treatment and SNT will be incredibly valuable NZT